跳至主要内容
临床试验/JPRN-UMIN000016985
JPRN-UMIN000016985已完成未知

Fast Antidepressant Efficacy and Central Mechanisms of Single Low-Dose Ketamine Injection in Treating Major Depression: a double-blind and randomized-controlled trial and image study - Single Low-Dose Ketamine Injection in Treating Major Depression

Ministry of Science and Technology0 个研究点目标入组 72 人开始时间: 2016年6月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • •1) Use of CNS intoxicant within the previous 24 hours or urine toxicology screen positive for drugs of abuse 2) Overdose, within previous 24 hours, of any agent which would compromise ketamine metabolism 3) Symptoms of substance abuse/dependence(except nicotine dependence) within 6 months 4) Lifetime use of ketamine or phencyclidine(PCP) 5) Diagnosis of psychosis or bipolar disorder

研究者

相似试验